These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9531437

  • 1. Comparison of IgM-MGUS and IgG-MGUS polyneuropathy.
    Simovic D, Gorson KC, Ropper AH.
    Acta Neurol Scand; 1998 Mar; 97(3):194-200. PubMed ID: 9531437
    [Abstract] [Full Text] [Related]

  • 2. Neuropathy associated with monoclonal gammopathies of undetermined significance.
    Gosselin S, Kyle RA, Dyck PJ.
    Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
    [Abstract] [Full Text] [Related]

  • 3. Prognosis of polyneuropathy due to IgM monoclonal gammopathy: a prospective cohort study.
    Niermeijer JM, Fischer K, Eurelings M, Franssen H, Wokke JH, Notermans NC.
    Neurology; 2010 Feb 02; 74(5):406-12. PubMed ID: 20124206
    [Abstract] [Full Text] [Related]

  • 4. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS.
    Suarez GA, Kelly JJ.
    Neurology; 1993 Jul 02; 43(7):1304-8. PubMed ID: 8327128
    [Abstract] [Full Text] [Related]

  • 5. Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients.
    Maisonobe T, Chassande B, Vérin M, Jouni M, Léger JM, Bouche P.
    J Neurol Neurosurg Psychiatry; 1996 Jul 02; 61(1):36-42. PubMed ID: 8676156
    [Abstract] [Full Text] [Related]

  • 6. IgM MGUS anti myelin-associated glycoprotein neuropathy can rarely express as a predominantly distal motor neuropathy.
    Galassi G, Tondelli M.
    Muscle Nerve; 2016 May 02; 53(5):827-8. PubMed ID: 26690862
    [No Abstract] [Full Text] [Related]

  • 7. IgM monoclonal gammopathy-associated neuropathies with different IgM specificity.
    Matà S, Borsini W, Ambrosini S, Toscani L, Barilaro A, Piacentini S, Sorbi S, Lolli F.
    Eur J Neurol; 2011 Aug 02; 18(8):1067-73. PubMed ID: 21261794
    [Abstract] [Full Text] [Related]

  • 8. Selective techniques of apheresis in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
    Siciliano G, Moriconi L, Gianni G, Richieri E, Vignocchi MG, Rossi B.
    Acta Neurol Scand; 1994 Feb 02; 89(2):117-22. PubMed ID: 8191874
    [Abstract] [Full Text] [Related]

  • 9. [Neurological manifestations of monoclonal gammopathies].
    Chassande B, Léger JM.
    Rev Prat; 1993 Feb 01; 43(3):314-6. PubMed ID: 8389055
    [Abstract] [Full Text] [Related]

  • 10. Immunostaining of skin biopsy adds no diagnostic value in MGUS-associated peripheral neuropathy.
    Al-Zuhairy A, Schrøder HD, Plesner T, Abildgaard N, Sindrup SH.
    J Neurol Sci; 2015 Feb 15; 349(1-2):60-4. PubMed ID: 25582978
    [Abstract] [Full Text] [Related]

  • 11. Antibodies to L-periaxin in sera of patients with peripheral neuropathy produce experimental sensory nerve conduction deficits.
    Lawlor MW, Richards MP, De Vries GH, Fisher MA, Stubbs EB.
    J Neurochem; 2002 Nov 15; 83(3):592-600. PubMed ID: 12390521
    [Abstract] [Full Text] [Related]

  • 12. The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings.
    Yeung KB, Thomas PK, King RH, Waddy H, Will RG, Hughes RA, Gregson NA, Leibowitz S.
    J Neurol; 1991 Oct 15; 238(7):383-91. PubMed ID: 1660064
    [Abstract] [Full Text] [Related]

  • 13. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
    Kuijf ML, Eurelings M, Tio-Gillen AP, van Doorn PA, van den Berg LH, Hooijkaas H, Stork J, Notermans NC, Jacobs BC.
    Neurology; 2009 Sep 01; 73(9):688-95. PubMed ID: 19720975
    [Abstract] [Full Text] [Related]

  • 14. Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies.
    Nobile-Orazio E, Barbieri S, Baldini L, Marmiroli P, Carpo M, Premoselli S, Manfredini E, Scarlato G.
    Acta Neurol Scand; 1992 Jun 01; 85(6):383-90. PubMed ID: 1379409
    [Abstract] [Full Text] [Related]

  • 15. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
    Lunn MP, Nobile-Orazio E.
    Cochrane Database Syst Rev; 2012 May 16; (5):CD002827. PubMed ID: 22592686
    [Abstract] [Full Text] [Related]

  • 16. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
    Steiner N, Schwärzler A, Göbel G, Löscher W, Wanschitz J, Gunsilius E.
    Oncotarget; 2017 Jan 17; 8(3):5081-5091. PubMed ID: 27974705
    [Abstract] [Full Text] [Related]

  • 17. [Neuropathy associated with dysglobulinemia and monoclonal gammopathy].
    Saito T.
    Nihon Rinsho; 1994 Nov 17; 52(11):2976-83. PubMed ID: 7996697
    [Abstract] [Full Text] [Related]

  • 18. Long-term clinical and neurophysiological follow-up of patients with peripheral, neuropathy associated with benign monoclonal gammopathy.
    Ponsford S, Willison H, Veitch J, Morris R, Thomas PK.
    Muscle Nerve; 2000 Feb 17; 23(2):164-74. PubMed ID: 10639606
    [Abstract] [Full Text] [Related]

  • 19. Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities.
    Notermans NC, Wokke JH, Lokhorst HM, Franssen H, van der Graaf Y, Jennekens FG.
    Brain; 1994 Dec 17; 117 ( Pt 6)():1385-93. PubMed ID: 7820574
    [Abstract] [Full Text] [Related]

  • 20. IgM-monoclonal gammopathy neuropathy and tremor: a first epidemiologic case control study.
    Ahlskog MC, Kumar N, Mauermann ML, Klein CJ.
    Parkinsonism Relat Disord; 2012 Jul 17; 18(6):748-52. PubMed ID: 22475624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.